About us:
your strategic
statistical partner
Statistical support
For clinical research and development.
We generate statistical evidence from clinical data to support regulatory, clinical, and Market Access decisions across clinical development, regulatory submissions, HTA, pricing, and reimbursement.
We transform data into evidence that drives confident decisions.
Understanding
Deep understanding of statistical methods, regulatory requirements, and HTA frameworks.
Flexibility
Flexible engagement models, including FSP and advisory, aligned with project needs.
Rigour
Robust statistical analyses for regulatory, pricing and reimbursement decisions.
Reach
Experience across DACH, EU5, Nordics, and multiple therapeutic areas.
We provide clinically relevant evidence – not black-box statistics. Our analyses deliver arguments, not just numbers, supporting HTA, including AMNOG and JCA, as well as approval decisions. We guide organisations through complexity with regulatory understanding, empathy, and clarity.
Let’s work together
In statistical support for Phase I–IV clinical studies
Clinical experience & statistical knowledge
Across a wide range of therapeutic areas, we support clinical development, regulatory submissions and Market Access decision-making.
From study planning to interpretation
Study planning & design
Statistical design review and planning aligned with study objectives and evidence requirements.
Data & quality
Data preparation and quality control to establish a reliable foundation for statistical analysis.
Analysis & modelling
Statistical analysis and modelling tailored to the research question and evidence requirements.
Interpretation & reporting
Clear interpretation and reporting that turns statistical results into meaningful evidence for research and assessment.
Our mission
At Numerus, we transform complex clinical data into clear, actionable statistical evidence that supports clinical, regulatory, and Market Access decision-making.
Our statistical knowledge enables confident and responsible decisions in evidence-based medicine. We aim to provide high-quality statistical services with scientific rigour, precision, and long-term reliability.
Our values & culture
Trusted partnerships
We build long-term, reliable relationships with our clients based on understanding, collaboration, and shared scientific goals.
Integrity in science
We ensure precision, transparency, and methodological rigour in all statistical analyses, guided by strong ethical standards.
Driving impact
We support progress in clinical research through robust statistical evidence that enables informed decision-making.
Clarity & respect
We communicate clearly, directly, and respectfully – ensuring transparency in both analysis and collaboration.
Our team
Our team brings together experienced biostatisticians, data managers, and project leads with a strong focus on clinical and regulatory decision support. Each project is supported by a dedicated lead, ensuring continuity from design to final delivery.
Team event
Stuttgart, 2025- People behind the science
Our team in conversation - Looking ahead
Shaping what comes next - Strategy workshop
Ideas, priorities and direction - Working together
Across projects and perspectives - Wall of ideas
Thinking together
Leadership
Strategic oversight with extensive experience in global clinical, regulatory, and Market Access environments.
- Jonathan Alsop & Martin Scott
Founders - People. Science. Direction.
Martin Scott
Scientific Director- Jonathan Alsop
Operations Director - Jochen Münch
Commercial Director - From complexity to clarity
Partners & scientific network
Connected to the scientific community
Numerus works closely with academic institutions, industry partners, CROs and international scientific networks. These connections help us stay close to methodological developments, attract new talent and bring the right capabilities together for complex projects.
Industry & CRO collaboration
We work with pharmaceutical, biotech, medtech organisations and CROs to combine complementary capabilities for larger programmes, complex evidence challenges and emerging methodological topics.
Academic network
We collaborate with universities and research institutions to connect with emerging statistical talent, exchange knowledge and stay close to new methods and developments in clinical research and HTA.
Your next evidence challenge
Have an evidence question?